American pharmaceutical company Pfiza, one of the world leaders in this industry, from January to September 2018, increased its net profit by 28% in annual terms to 11 billion 546 million dollars, finversia.ru writes, referring to the company's statements. Earnings per share rose to 1 dollar 92 cents from 1 dollar 49 cents a year earlier. Revenue increased by 2% and amounted to 39 billion 700 million dollars. In the third quarter, Pfiza net profit increased 1.5 times, and its revenue increased by 1%. At the same time, in the sector of basic medical goods and services a decrease by 4% was observed.
Fed balance sheet rises $5 trillion for the first time since financial crisis26.03.2020
Singapore prepares for recession as virus-hit economy drops in first quarter24.03.2020
SoftBank shares climb up to 20% following buyback announcement20.03.2020
First round of QE sees Australia central bank buy $2.9 billion bonds